Drug combination extends survival in refractory lung cancer patients, study finds

Thursday, June 2, 2011 - 09:30 in Health & Medicine

A combination of two FDA-approved drugs extend survival in advanced-stage lung cancer patients who have run out of treatment options, according to a new study.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net